tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

PRNAF Stock Latest News

BNYMC Ups Stake in Alterity Therapeutics
Company AnnouncementsBNYMC Ups Stake in Alterity Therapeutics
3d ago
Appendix 4C – Q3 FY24 Quarterly Cash Flow Report
PremiumPress Releases
Appendix 4C – Q3 FY24 Quarterly Cash Flow Report
5d ago
ATHE
Alterity Therapeutics reports cash position of A$18.3M as of March 31
PremiumThe Fly
Alterity Therapeutics reports cash position of A$18.3M as of March 31
5d ago
ATHE
Alterity Therapeutics presents new data demonstrating potential of ATH434
PremiumThe Fly
Alterity Therapeutics presents new data demonstrating potential of ATH434
6d ago
ATHE
Alterity Therapeutics Presents New Data Demonstrating Potential of ATH434 to Treat Rare Neurodegenerative Disease Friedreich’s Ataxia
PremiumPress Releases
Alterity Therapeutics Presents New Data Demonstrating Potential of ATH434 to Treat Rare Neurodegenerative Disease Friedreich’s Ataxia
6d ago
ATHE
Alterity Therapeutics Aims for ASX Listing Boost
PremiumCompany AnnouncementsAlterity Therapeutics Aims for ASX Listing Boost
7d ago
Alterity Therapeutics’ Breakthrough in Rare Disease Treatment
PremiumCompany Announcements
Alterity Therapeutics’ Breakthrough in Rare Disease Treatment
7d ago
Alterity announces presentations of data on Parkinson’s Disease, MSA
PremiumThe Fly
Alterity announces presentations of data on Parkinson’s Disease, MSA
18d ago
ATHE
Alterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting
PremiumPress Releases
Alterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting
18d ago
ATHE
Alterity Therapeutics Unveils Promising Neurological Data
PremiumCompany Announcements
Alterity Therapeutics Unveils Promising Neurological Data
19d ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
20d ago
OCX
AGEN
Alterity Therapeutics Applies for New Options Quotation
PremiumCompany Announcements
Alterity Therapeutics Applies for New Options Quotation
21d ago
Alterity Therapeutics Launches Exclusive Options Offer
PremiumCompany AnnouncementsAlterity Therapeutics Launches Exclusive Options Offer
24d ago
Alterity Therapeutics’ Resolutions Pass Unanimously
PremiumCompany Announcements
Alterity Therapeutics’ Resolutions Pass Unanimously
24d ago
Alterity Therapeutics to Present New Data on ATH434 at the World Orphan Drug Congress USA 2024
PremiumPress Releases
Alterity Therapeutics to Present New Data on ATH434 at the World Orphan Drug Congress USA 2024
25d ago
ATHE
Alterity Unveils Progress on Neurodegenerative Drug ATH434
PremiumCompany Announcements
Alterity Unveils Progress on Neurodegenerative Drug ATH434
26d ago
Alterity Therapeutics Receives a A$3.9 Million Research & Development Tax Incentive Refund
PremiumPress Releases
Alterity Therapeutics Receives a A$3.9 Million Research & Development Tax Incentive Refund
1M ago
ATHE
Alterity Therapeutics receives A$3.9M R&D Tax Incentive refund
PremiumThe Fly
Alterity Therapeutics receives A$3.9M R&D Tax Incentive refund
1M ago
ATHE
Alterity Therapeutics Ltd (ADR) trading halted, news pending
PremiumThe Fly
Alterity Therapeutics Ltd (ADR) trading halted, news pending
2M ago
ATHE
Alterity Therapeutics to Present New Data at the Upcoming American Academy of Neurology 2024 Annual Meeting
PremiumPress ReleasesAlterity Therapeutics to Present New Data at the Upcoming American Academy of Neurology 2024 Annual Meeting
3M ago
ATHE
Alterity Therapeutics says Phase 2 DMC recommends continuation of trial
PremiumThe Fly
Alterity Therapeutics says Phase 2 DMC recommends continuation of trial
3M ago
ATHE
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Second Review
PremiumPress Releases
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Second Review
3M ago
ATHE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >